October 22, 2019 - Paul-Ehrlich-Institut, Langen, Germany

Quality Requirements for Challenge Agents
An IABS-EU Meeting

SAVE THE DATE

Meeting Objectives
One of the proposed tools for faster development of new vaccines is CHIM: Controlled Human Infectious Models. These models can be used for early PoC (Proof of Concept) and as a basis for clinical  “Go/No Go” decisions, in particular if sporadic epidemiology impedes clinical development.
In these models researchers will use a challenge agent: a virus, bacterium or parasite. Frequently questions are raised on the quality of the agent. Should this agent be produced following GMP? What strain-related information is relevant?  Should it be attentuated or resemble the wild type?

These questions will be discussed during this symposium, more information will follow soon

View the Agenda

 

Use the buttons below if you would like to share this info :

International Alliance for Biological Standardization


Twitter Feed

Register for IABS #RabiesElimination conference. Bangkok. December 3-4, 2019 Topic: Global Strategic Plan for the… https://t.co/4Ead5Fd0dS
IABS #diagnosticsveterinary workshop. Topic: Survival of viral pathogens in animal feed ingredients under transboun… https://t.co/Mpx7gHZZ6V
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.